Company tells NSE the imported menopause-care product contributes less than 1% of revenue and the disruption is not expected to materially affect financial performance
Company says voluntary dissolution of wholly owned subsidiary will have no material impact on business, with entity contributing nil revenue in FY26
Company says operations will continue for 15 days, corrective measures underway as it seeks revocation of closure order
Inspection at New York manufacturing facility concludes with a single Form 483 observation; company to submit corrective response
The acquisition gives GSK access to three promising lung cancer programmes
DST funding will help K.N. Biosciences commercialise IIT Guwahati's natural blue pigment technology, reducing import dependence and boosting India's bio-manufacturing ecosystem
The 12-week certification program is designed to provide students with industry-relevant knowledge through intensive modules across multiple scientific disciplines
The acquisition of Integrace further strengthens the firm's healthcare investment strategy and reflects growing investor confidence in India's branded formulations market
Senior scientists from Lupin, Mankind Pharma | Bharat Serums and Vaccines, Zydus Lifesciences, Panacea Biotec, Veeda Lifesciences, Shilpa Biologicals, Zumutor Biologics, InoRx and Mumbai Biocluster will discuss India's roadmap to becoming a global biosimilars and biologics hub
Zero-tariff access under the India-UK CETA is expected to boost generic medicine exports, strengthen supply chains and deepen investment and R&D partnerships
Company says active ingredient is clearly disclosed on all Aciloc packs and pledges full cooperation with authorities
Rs. 1,060-crore acquisition strengthens NATCO’s long-term growth strategy in the African pharmaceutical market
Exclusive marketing alliance brings gastro-protective pain management therapy for patients requiring long-term NSAID treatment
Supply chain veteran with over 24 years of experience to strengthen distribution and logistics operations
The event will welcome women across age groups and fitness levels, reinforcing its message that health and fitness are for everyone
The acquisition strengthens NATCO Pharma's strategic presence in the African pharmaceutical market through Adcock Ingram, one of South Africa's leading pharmaceutical manufacturers and healthcare companies
Apollo-managed funds and affiliates will acquire a minority, non-controlling stake in a newly established entity
Subscribe To Our Newsletter & Stay Updated
